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HLA-A, -B, -DR and -DQ antigen profile was studied in pulmonary tuberculosis patients (n=209) and
their spouses (family contacts; n=50) and healthy volunteers (n=72). An increased frequency of HLA-
A-10, B7, B15, DR2 and DQ1 was seen in the pulmonary-TB (PTB) patients when compared to the
total control subjects (n=122). However, a significant increase was seen only with HLA-DR2 (P <
0.001; Pc < 0.01; Relative Risk 2.3) and -DQ1 (P < 0.005; Pc<0.015; Relative Risk 2.8). Among the
spouses and the corresponding patients, a similar increase of HLA-DR2 was seen. A decreased
frequency of HLA-A19, B8, B17, B35, DR5 and DR6 were seen in PTB as compared to control groups.
The present study suggested that HLA-DR2 and DQ1 genes/gene products may be associated with the
susceptibility to tuberculosis either alone or in combination with other HLA or non-HLA genes.
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Pulmonary tuberculosis is a granulomatous lung
disease caused by Mycobacterium tuberculosis.
Susceptibility to tuberculosis has been suggested to
be multifactorial. Though environmental and socio-
economic factors are primarily related, numerous
studies have emphasised the importance of host
resistance and hereditary susceptibility1,2.
Studies on HLA and susceptibility to tuberculosis
have been carried out in various populations as well
as families by different groups in different parts of
the world. The first report by Selby et al 3 showed an
increased frequency of HLA-B8 in tuberculosis
patients in Canada. A large number of studies have
also been carried out in various populations4-8. All
these studies suggest that different HLA antigens are
associated with pulmonary tuberculosis in different
populations.
Interestingly, studies carried out in Asian
populations revealed an increased frequency of HLA-
DR2 in Indian8-10, Indonesian11 and Russian12
pulmonary tuberculosis patients. Further, DR2
subtyping revealed no deviation in the frequency of
common DR2 subtypes  (1501 and  1502)  in
pulmonary TB (PTB), suggesting that the whole DR2
molecule or its closely linked gene(s) may be
involved in PTB10. Earlier HLA studies in pulmonary
TB in India were based on general population or
hospital contacts as controls, where the gene
frequency of HLA-DR2 is high13.
The present study was carried out to delineate
HLA-DR2 association with pulmonary TB using
the  spouses  of  the  pulmonary  TB pat ients
considered to be a resistant population as the
control population.
Material & Methods
Study subjects :
(i) Active tuberculosis patients (ATB) – Patients
attending the Tuberculosis Research Centre (TRC),
Chennai, with respiratory symptoms and radiographic
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abnormalities suggestive of pulmonary TB were
studied. These patients had sputum positive for M.
tuberculosis by smear and culture.
(ii) Inactive tuberculosis patients (ITB) – These
patients had had active pulmonary TB and had
received short course chemotherapy for 6-8 months,
10-15 yr earlier. At the time of blood sample
collection all the patients were in the quiescent stage
of the disease.
(iii) Controls – The group comprised spouses of
the ITB patients living together for 10-15 yr and
spouses of ATB patients (living together for 1-2 yr
at the time of assessment) and staff members working
in TRC for more than 3 yr.
There was no consanguinity between the patients
and spouses. The other control subjects were not
related to any of the patients. All the family contacts
and other control subjects were clinically normal at
the time of assessment. All subjects belonged to the
same ethnic origin and the patients and controls were
randomly selected from the same ethnic group and
were mainly Tamil speaking south Indians living in
and around Chennai. The study group comprised all
communities belonging to the same ethnic group.
Subjects included in this study were 61 active
pulmonary tuberculosis patients, 148 inactive
tuberculosis patients (cured/quiescent) (total
pulmonary TB patients 209) and 122 healthy controls
including 50 family contacts (spouses) and clinicians,
social workers, health visitors, laboratory volunteers
and other staff (n=72) working in TRC for more than
3 yr. Of the 50 family contacts studied, six were
spouses of ATB patients and 44 the spouses of ITB
patients.
Among the total PTB patients, 164 were males
and 45 were females. The mean age (±SE) was
39.8±0.8 yr for males and 35.9±1.4 for females.
Among the family contacts 13 were males and 37
were females. The mean age was 35.5±2.2 for males
and 35.8±1.3 for females. Among the TRC volunteer
control subjects, 40 were males and 32 were females.
The mean age was 40.3±1.2 for males and 39.1±1.8
for females.
Twenty millilitres of peripheral blood in heparin
(20 units/ml) was drawn from each patient. The
mononuclear cells were separated using ficoll-
hypaque density gradient centrifugation and washed
in TC 199 tissue culture medium and used for HLA
typing. The nylon wool non-adherent cells (enriched
T cells) were used for HLA-A, -B typing and the
adherent population (enriched B cells) were used for
HLA-DR and -DQ typing. HLA phenotyping was
performed by a two stage microlymphocytotoxicity
assay14. The antisera for HLA-A, -B, -DR and -DQ
antigens were purchased from Biotest, Germany. In
addition to the above sera, well established sera of
local origin and sera procured from co-operative HLA
laboratories in India were also used. At least three
sera were included for each specificity studied.
The frequencies of HLA alleles in patients and
controls were determined by direct allelic count
method. A 2 x 2 contingency table was constructed
and Chi-square analysis with Yates correction (X2y)
was performed to find out the significance for HLA
antigens. Significant P-values were further corrected
(Pc) by multiplying the P-value for the number of
antigens studied for each locus. Relative Risk (RR)
values were calculated to find out the strength of
association of HLA antigens and the occurrence of
pulmonary tuberculosis.
Results & Discussion
Among the active-TB and inactive-TB patients,
no difference was observed on the phenotype
frequency of various HLA antigens. The data were
amalgamated and analysed as one group as pulmonary
TB patients.
An increased frequency of HLA-B7, -B15, -DR2
and -DQ1 was seen in pulmonary tuberculosis
patients than the total control subjects (Table). The
frequencies of B7 and B15 were only trends and not
significant when corrected for the number of antigens
studied for that locus (HLA-B7 : PTB vs total
controls: P < 0.05; PC > 0.5). A similar trend was
also observed in spouses (family contacts). A
significant increase in the antigen frequency of HLA-
DR2 and -DQ1 was seen in pulmonary tuberculosis
patients than control subjects (total control vs
PTB:HLA-DR2 : P < 0.001; Pc < 0.01; HLA-DQ1:
P < 0.005; Pc < 0.015). An increase in the frequency
of HLA-DR.2 was observed in the PTB patients as
compared to their spouses (P < 0.05), while the
frequencies of HLA-DR5 and -DR6 were decreased
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Table. Percentage phenotype frequency of deviated HLA-A, -B,
-DR and - DQ antigens of control (total) subjects, PTB patients
(total), spouses (family contacts) and their corresponding PTB
patients
HLA % PF
Control PTB patients Spouses** PTB patients**
n=122 n=209 n=48 n=48
A10 7.4 13.9 8.3 14.6
A19 32.0 23.0 27.1 18.8
B7 17.2 27.8 12.5 23.0
B8 7.4 3.8 10.4 2.1
B15 9.8 16.3 8.3 14.6
B17 29.5 18.7 22.9 12.5
B35 28.7 19.1 25.0 20.1
DR2 29.5 48.8 25.0 47.9
DR5 19.7 16.3 22.9 8.3
DR6 19.7 17.7 29.2 12.5
DQ1 68.0 85.6 70.8 83.3
I. Total controls vs total PTB patients
i. HLA-B7 : P < 0.05; Pc > 0.5;
ii. HLA-B17 : P < 0.025; Pc > 0.30; B35 : P < 0.05;
Pc > 0.5;
iii. HLA-DR2 : P < 0.001; Pc < 0.01; DR 2 RR value 2.3;
iv. HLA-DQ1 : P < 0.005; Pc < 0.015 RR value 2.8.
II. Spouses vs corresponding PTB patients
i. HLA-B8 : P < 0.05;
ii. HLA-DR2 : P < 0.05; RR value : 2.7;
iii. HLA-DR5 : P < 0.025;
iv. HLA-DR6 : P < 0.025
* * HLA not done for two patients and the corresponding spouses
were not included (total number of spouses studied n = 50)
in the patients as compared to the spouses (DR5 :
P < 0.025; DR6 : P < 0.025). This trend of decreased
frequency of DR5 and DR6 was not seen in the PTB
patients as a total group when compared to controls
as a total group.
Previous investigations of HLA and disease
association in pulmonary tuberculosis patients
showed a varied picture in different populations,
mainly because of the geographical distribution of
the antigens and the ethnic background of the
populations -1.3 2 However, studies carried out in Asian
region especially India8-10; Indonesia11 and Russia12
showed a definite association of HLA-DR2 and
-DQ1 with pulmonary tuberculosis. It is well
established that DR2 is in linkage disequilibrium
with DQ1.
The association of HLA-DR2 with the severity of
pulmonary tuberculosis in Indian population has been
emphasized. In south Indian patients with PTB, DR2
has been shown to be more strongly associated with
far-advanced, smear positive cases than with cases of
minimal and moderate radiographic lung lesion8. It
has been shown that DR2 is associated with patients
with chronic fibrocavitory disease who failed to react
to PPD in skin test12. Further, high frequency of DR2
among north Indian PTB patients was seen in the
drug-failure group who received multiple drugs
compared with the frequency of healthy controls and
drug responders 10. Though the severity of the disease
is associated with HLA-DR2, our earlier study on
bacteriological relapse in pulmonary tuberculosis
patients treated with short chemotherapy did not
reveal any deviation in the DR2 frequency from that
of quiescent patients15.
It has been shown that PTB patients bearing DR2
antigen had higher levels of antibodies to M.
tuberculosis than other patients12. Further, there is
evidence for an immune spectrum in tuberculosis
wherein the cell-mediated and humoral immunity are
mutually exclusive at opposing ends of the
spectrum .16 Our recent study reveals that active
tuberculosis patients with DR2 showed a trend
towards a higher antibody response to M. tuberculosis
antigen, suggesting that the higher antibody titre
may suppress the CMI response in DR2 positive
patients (unpublished). Further, our earlier study
revealed a decreased level of plasma lysozyme
(lysosomal enzyme) in the DR2 positive active PTB
patients as compared to DR2 negative patients17. The
data suggest that susceptibility to pulmonary
tuberculosis is not only influenced by HLA-DR2
genes/gene products alone but also by other non-
HLA gene factors.
Recently, the association of multi candidate genes
has been suggested for various infectious diseases18.
A study carried out in north Indian PTB patients
revealed that transporter associated with antigen-
processing gene TAP2 is associated with PTB along
with HLA-DR219. Recently, our studies on non-HLA
gene polymorphism in pulmonary tuberculosis
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revealed that functional mutant homozygotes of
mannose binding protein genes are associated with
pulmonary tuberculosis independent of HLA-DR2
(unpublished data). This suggests that HLA-DR2
genes/gene products in combination with other MHC
or non-MHC genes, play a major role in susceptibility
to pulmonary tuberculosis.
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